These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35104421)

  • 1. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic Cancer.
    Jiang F; Huang X; Zhang F; Pan J; Wang J; Hu L; Chen J; Wang Y
    DNA Cell Biol; 2022 Mar; 41(3):305-318. PubMed ID: 35104421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
    Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
    Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
    Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
    EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis.
    Ding W; Wang Y; Ma Y; Lin L; Li M
    Dis Markers; 2022; 2022():3839480. PubMed ID: 36061357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.
    Ma X; Tao R; Li L; Chen H; Liu Z; Bai J; Shuai X; Wu C; Tao K
    Oncol Rep; 2019 Jan; 41(1):292-300. PubMed ID: 30365134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer.
    Cao M; Zhang PB; Wu PF; Chen Q; Ge WL; Shi GD; Yin J; Cai BB; Cao SJ; Miao Y; Jiang KR
    Biomed Res Int; 2021; 2021():6530298. PubMed ID: 33748270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain 8 as a potential biomarker regulates the progression of pancreatic cancer via EMT and AKT/ERK pathway.
    Song N; Cui K; Zeng L; Fan Y; Wang Z; Shi P; Su W; Wang H
    J Proteomics; 2024 Jun; 301():105182. PubMed ID: 38697284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer.
    Chen Y; Wang C; Song J; Xu R; Ruze R; Zhao Y
    Front Immunol; 2021; 12():758004. PubMed ID: 34887861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
    Liu S; Cai Y; Changyong E; Sheng J; Zhang X
    Pathol Oncol Res; 2021; 27():1609868. PubMed ID: 34321959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic Analysis of Prognostic and Immune-Related Genes in Pancreatic Cancer.
    Li Z; Hu C; Yang Z; Yang M; Fang J; Zhou X
    Comput Math Methods Med; 2021; 2021():5549298. PubMed ID: 34394706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.
    Zheng X; Liu X; Zheng H; Wang H; Hong D
    Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
    Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
    PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of Myoferlin in Human Pancreatic Cancer via Bioinformatics.
    Pi R; Chen Y; Du Y; Dong S
    Biomed Res Int; 2021; 2021():2602322. PubMed ID: 34957301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer.
    Fan Y; Li T; Xu L; Kuang T
    Comput Math Methods Med; 2020; 2020():6138039. PubMed ID: 33062039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
    Jia Y; Shen M; Zhou Y; Liu H
    Acta Biochim Pol; 2020 Dec; 67(4):501-508. PubMed ID: 33253517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
    Xu D; Wang Y; Zhou K; Wu J; Zhang Z; Zhang J; Yu Z; Liu L; Liu X; Li B; Zheng J
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
    Yang A; Wang X; Hu Y; Shang C; Hong Y
    Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
    Chang X; Yang MF; Fan W; Wang LS; Yao J; Li ZS; Li DF
    J Comput Biol; 2020 Nov; 27(11):1595-1609. PubMed ID: 32216644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.